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Abstract
Preoperative embolization plays a significant role as an
adjunct to surgical intervention in the cases of certain
vascular tumours of the brain. While the procedure has
resulted in facilitated resection of the tumour, and has
reduced morbidity and mortality, its application remains
debatable within the neurosurgical community, owing to
rare, but major post-procedural complications. Herein, we
have reviewed the literature to assess the safety and
efficacy of preoperative angiographic embolization for
brain tumours.  
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Introduction
Despite advances in microsurgical techniques,
management of vascular brain tumours is complex, and
requires a multi-disciplinary approach.1,2 Pre-operative
embolization (PEm) was first described in the 1970s, and
has slowly gained acceptance amongst the neurosurgical
community, as an adjunct to brain tumour surgery for
hyper-vascular tumours.1 Tumour embolization refers to
any procedure performed either percutaneously, through
a direct puncture of the tumour (DPT),  or via a trans-arterial
approach, in which embolic material is injected with the
goal of reducing tumour vascularity, hence, minimizing
morbidity and improving chances of successful tumour
resection.1 The latter is facilitated through necrotic
softening of the tumour, making it more easily resectable.3
Embolization of extra-axial tumours such as meningiomas,
performed in the territory of external carotid artery (ECA),
is generally safer than embolization of intra-axial tumours
such as haemangioblastoma, which derive their vascular
supply from internal carotid artery (ICA) or vertebrobasilar
artery (VBA).2 Most commonly employed embolisates
include particles such as Poly Vinyl Alcohol (PVA) and
trisacryl gelatin microspheres (TAGM), as well as liquid
embolic agents such as Onyx and N-Butyl Cyanoacrylate
(NBCA).3 There are multiple objectives for pre-operative
devascularization of the tumour, the most important being
minimizing blood loss, and decreasing operating time.
Other benefits include their use in palliation, by decreasing
tumour size and reducing pain in patients not fit for
surgery.1
However, some authors have questioned the utility of PEm,
in the light of questionable cost-effectiveness and the risk
of post-procedural complications. In this paper, we have
reviewed the technical efficacy, safety, and outcomes of
pre-operative brain tumour embolization. 
Review of Literature 
Kubota et al., published a case of a patient undergoing
surgery for a huge, right-sided tentorial epithelioid
haemangioendothelioma (E-HE), in which authors had to
abort surgery due to haemorrhage. The patient underwent
embolization with PVA of the right ECA partially feeding
the tumour five days before second surgery. Subsequent
gross-total removal of the tumour was relatively bloodless,
and no recurrence was reported even nine years later,
suggesting PEm to be rational in cases of E-HE.4 Duffis et
al., proposed their highly cited guidelines for embolization
in 2012.1 Non-invasive imaging was suggested to allow
delineation of the extent of tumour and digital subtraction
angiography (DSA), along with super-selective
catheterization of ECA was recommended to allow for
identification of displaced feeders, presence of collateral
flow distal to the involved carotid; and to reveal intracranial
anastomoses. Tumour blush was proposed as a radiologic
measure of procedural efficacy. According to the authors,
tumour resection within 24 hours of embolization was to
be avoided and a delay of 1 to 8 days from embolization
was recommended. However, the timing for surgery after
embolization remains controversial and some authors
advocate resecting the neoplasm immediately, or within a
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Figure:  A) and B), Digital subtraction angiogram, pre and post embolization lateral
views, of a meningioma supplied by the ECA.
A) B)
day, to avoid potential worsening of peritumoral oedema.5
Steroid use was also advised in tumours at risk of post-
embolization oedema. 
Wang et al., published the outcome of PEm in eight
paediatric brain tumour patients over eight years, and
reported good results with embolization as a surgical
adjunct.2 Embolization was done with either NBCA or
TAGM. Four out of the eight cases were of choroid plexus
papilloma, and two of these patients, both embolized with
TAGM, developed tumour bleeds.2 Hanak et al.,
retrospectively reviewed 15 patients, who underwent 17
PEm for haemangiopericytomas (HPC) at two centers. More
extensive devascularization was achieved for HPCs with
primarily ECA blood supply, than those with ICA/VBA
circulation. The authors reported an average time interval
of 2.2 days between embolization and surgery, with no
greater than 500 ml blood loss in tumours that achieved
80% devascularization. The authors, however, did not
notice any significant difference in gross total removal of
embolized versus non-embolized tumours.3
In a systematic review of PEm for intradural spinal
haemangioblastoma (HB), Ampie et al., analyzed 29
reported cases. The most commonly utilized embolisate
was (PVA), followed by TAGM and NBCA. Excellent rates of
gross total resection (GTR) were reported, with estimated
blood loss (EBL) averaging up to 187.5 ml. Complications
from embolization and surgery were minimal, with no
deaths or permanent neurological morbidity. The authors,
however, noted excellent outcomes from microsurgery
alone from historical series, questioning the rationale
behind PEm.6 In another systematic review for intracranial
HB, Ampie et al., reported that PEm did not increase GTR
rates and failed to reduce blood loss and complications,
rather itself significantly carrying the aforementioned risks.
In a total of 111 patients compared to 392 non embolized
ones, GTR was achieved in 83.7% and 95.6% of the patients,
respectively. Intraoperative blood transfusion was required
in 15.3% of embolized and 0.51% of non-embolized
controls, while rates of postoperative haemorrhage were
8.4% and 1.6%, respectively. Complication rates from
embolization were 11.7% and following consequent
surgery were 20.7%, deeming PEm as inconsequential in
the authors’ view.5
Ampreechakul et al., examined the efficacy of PEm in a
retrospective analysis of 37 tumours, which included 18
meningiomas, six haemangioblastomas, and six
haemangiopericytomas, among others.7 Indications to
embolize included bleeding diatheses, hypervascular
tumour type, presence of multiple flow-voids on MRI, deep-
seated tumours, and tumours with intratumoral
aneurysms. Failure of PEm occurred in four patients and
median time to surgery after PEm was seven days.
Statistically significant negative correlation of angiographic
devascularization percentage and EBL was noticed, proving
the former to be the only true predictor of procedural
efficacy. In a prospective study of 14 patients, Gruber et al.,
described longitudinal image changes in supratentorial
hemispheric meningiomas based on MRI after PEm using
calibrated microspheres. The authors reported sustainable
tissue transformation and significant decrease in specific
parameters such as baseline apparent diffusion coefficient;
baseline mean ratios of relative cerebral blood volume,
relative cerebral blood flow, and viable enhanced baseline
mean tumour volume, within 6 hours and 48 hours of
embolization.8
More recently, Barros et al., published their retrospective
analysis of 139 meningiomas, describing anatomic
locations and vascular supplies to identify characteristics
predictive of successful PEm. Seventy-eight percent of
tumours were successfully embolized, with a 2.8%
periprocedural complication rate. Within the subset of
patients with successful embolization, 31% achieved
complete angiographic embolization. Significant
multivariate predictors of embolization were
meningohypophyseal trunk, middle meningeal artery, and
ascending pharyngeal artery supply, as well as convexity
or parasagittal location, the latter two most likely to achieve
complete angiographic embolization.9
Duffis et al., reported stroke and intracerebral haemorrhage
in up to 3-6% cases of PEm. While both particulate and
liquid emolisates were used, the former was linked to
greater complication rates, a notion supported by Wang et
al., too.1,2 In another study with intradural spinal HB cases
undergoing PEm, transient post-embolization
complications were rare, and included swallowing difficulty
(3.5%), decreased position sense (3.5%), and spasticity
(3.5%).6 However, in the cerebellar subset of the same
tumour, complications were more common, and included
post-procedural haemorrhage, ischaemic infarcts,
dysarthria, hemiparesis, and hemisensory impairment,
although mortality rates were not significantly different
compared to non-embolized cohort.5 In their retrospective
review of 39 patients, Tanaka et al., described five patients
with worsening of existing neurological symptoms,
explained as an inflammatory response, a condition they
termed as post-embolization neurological syndrome
(PENS).10 In another retrospective analysis of PEm in
meningioma patients by Barros et al., the authors reported
three procedure-related complications including middle
meningeal artery that required coiling; self-resolved
catheter-induced vasospasm, and a cervical ICA dissection.9
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Conclusion
PEm of hypervascular brain tumours has a high technical
success rate as a surgical adjunct, but also carries a
reasonable risk of complications. The authors therefore
recommend judicious utilization of this treatment adjunct.
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